ASSESSING OUTCOMES OF PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS AND INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Garg, Kanika [1 ]
Eswaran, Sheila L. [2 ]
机构：
[1] Rush Univ, Med Ctr, Internal Med, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Dept Hepatol, Chicago, IL 60612 USA
来源：
HEPATOLOGY | 2021年 / 74卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1243
引用
收藏
页码：745A / 746A
页数：2
相关论文
共 50 条
  • [41] Extraintestinal Cancers and Mortality in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease
    Ananthakrishnan, Ashwin N.
    Cagan, Andrew
    Cheng, Su-Chun
    Gainer, Vivian S.
    Cai, Tianxi
    Shaw, Stanley
    Szolovits, Peter
    Churchill, Susanne
    Karlson, Elizabeth W.
    Murphy, Shawn N.
    Kohane, Isaac
    Liao, Katherine P.
    GASTROENTEROLOGY, 2014, 146 (05) : S906 - S906
  • [42] Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran
    Hadizadeh, Mohammad
    Abedi, Seyed H.
    Malekpour, Habib
    Radinnia, Ebrahim
    Jabbehdari, Sayena
    Padashi, Maryam
    Zali, Mohammad R.
    Alizadeh, Amir H. Mohammad
    ARAB JOURNAL OF GASTROENTEROLOGY, 2016, 17 (01) : 17 - 19
  • [43] Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India
    Singh, Arshdeep
    Midha, Vandana
    Narang, Vikram
    Kedia, Saurabh
    Mahajan, Ramit
    Dhoble, Pavan
    Kahlon, Bhavjeet Kaur
    Dhaliwal, Ashvin Singh
    Tripathi, Ashish
    Kalra, Shivam
    Jain, Narender Pal
    Bansal, Namita
    Banerjee, Rupa
    Desai, Devendra
    Dutta, Usha
    Ahuja, Vineet
    Sood, Ajit
    INTESTINAL RESEARCH, 2023, 21 (04) : 452 - 459
  • [44] EFFECTIVENESS OF ADALIBUMAB FOR PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Franceschet, I.
    Cazzagon, N.
    Floreani, A.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E41 - E41
  • [45] EFFECTIVENESS OF ADALIBUMAB FOR PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE
    Franceschet, I.
    Cazzagon, N.
    Floreani, A.
    DIGESTIVE AND LIVER DISEASE, 2015, 47 : E191 - E191
  • [46] CLINICAL PRESENTATION AND OUTCOMES OF PRIMARY SCLEROSING CHOLANGITIS AND AUTOIMMUNE HEPATITIS IN INFLAMMATORY BOWEL DISEASE
    Martins, Camilla A.
    Caon, Ana Elisa R.
    Cruz, Marilia G.
    Barros, Luisa L.
    Carlos, Alexandre
    Azevedo, Matheus
    Queiroz, Natalia S.
    Milani, Luciane R.
    Terrabuio, Debora R.
    Cancado, Eduardo Luiz Rachid
    Damiao, Aderson O.
    GASTROENTEROLOGY, 2020, 158 (06) : S732 - S733
  • [47] Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease
    Manninen, Pia
    Karvonen, Anna-Liisa
    Laukkarinen, Johanna
    Aitola, Petri
    Huhtala, Heini
    Collin, Pekka
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (04) : 423 - 428
  • [48] Identification of the Predictive Factors of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease
    Sasson, Mark
    Ghali, Peter
    Wong, Phil
    Bessissow, Talat
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S331 - S331
  • [49] Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort
    Liu, Ken
    Wang, Ruoxi
    Kariyawasam, Viraj
    Wells, Mark
    Strasser, Simone I.
    McCaughan, Geoff
    Corte, Crispin
    Leong, Rupert W.
    LIVER INTERNATIONAL, 2017, 37 (03) : 442 - 448
  • [50] Primary Sclerosing Cholangitis and Distribution of Inflammatory Bowel Disease Reply
    O'Toole, Aoibhlinn
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2012, 10 (12) : 1418 - 1419
12345